Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$6.39 - $16.24 $32,429 - $82,417
-5,075 Reduced 0.7%
715,449 $6.01 Million
Q1 2022

May 10, 2022

BUY
$12.79 - $21.64 $973,817 - $1.65 Million
76,139 Added 11.82%
720,524 $9.95 Million
Q4 2021

Feb 14, 2022

BUY
$17.49 - $26.72 $692,866 - $1.06 Million
39,615 Added 6.55%
644,385 $13.2 Million
Q3 2021

Nov 15, 2021

BUY
$17.47 - $27.49 $5.44 Million - $8.55 Million
311,189 Added 106.0%
604,770 $15.1 Million
Q2 2021

Aug 10, 2021

BUY
$23.73 - $27.98 $6.97 Million - $8.21 Million
293,581 New
293,581 $6.97 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $202M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.